Guilin Sanjin Pharmaceutical Co Ltd (002275) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Based on the latest financial reports, Guilin Sanjin Pharmaceutical Co Ltd (002275) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.62 Million ≈ $17.21 Million USD) by net assets (CN¥3.24 Billion ≈ $474.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check strategic asset allocation of Guilin Sanjin Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.

Guilin Sanjin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Guilin Sanjin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See net assets of Guilin Sanjin Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.

Guilin Sanjin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guilin Sanjin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shanghai Aladdin Biochemical Technology Co. Ltd. A
SHG:688179
N/A
Orezone Gold Corporation
AU:ORE
0.249x
Trican Well Service Ltd.
TO:TCW
0.127x
Hapvida Participações e Investimentos S.A.
SA:HAPV3
-0.014x
Shunfa Hengye Corp
SHE:000631
0.000x
Topscore Fashion
SHG:603608
0.016x
Rackspace Technology Inc
NASDAQ:RXT
-0.004x
Xiamen East Asia Machinery Industrial Co. Ltd.
SHE:301028
N/A

Annual Cash Flow Conversion Efficiency for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Guilin Sanjin Pharmaceutical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 002275 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.01 Billion
≈ $440.42 Million
CN¥588.33 Million
≈ $86.09 Million
0.195x +0.25%
2023-12-31 CN¥2.82 Billion
≈ $412.21 Million
CN¥549.25 Million
≈ $80.37 Million
0.195x +3.76%
2022-12-31 CN¥2.81 Billion
≈ $411.68 Million
CN¥528.67 Million
≈ $77.36 Million
0.188x +30.08%
2021-12-31 CN¥2.84 Billion
≈ $415.55 Million
CN¥410.24 Million
≈ $60.03 Million
0.144x -28.52%
2020-12-31 CN¥2.96 Billion
≈ $433.00 Million
CN¥597.99 Million
≈ $87.50 Million
0.202x +21.50%
2019-12-31 CN¥2.82 Billion
≈ $411.99 Million
CN¥468.29 Million
≈ $68.52 Million
0.166x -15.39%
2018-12-31 CN¥2.81 Billion
≈ $410.70 Million
CN¥551.73 Million
≈ $80.73 Million
0.197x +34.52%
2017-12-31 CN¥2.65 Billion
≈ $388.35 Million
CN¥387.82 Million
≈ $56.75 Million
0.146x -33.97%
2016-12-31 CN¥2.43 Billion
≈ $354.94 Million
CN¥536.85 Million
≈ $78.56 Million
0.221x +30.14%
2015-12-31 CN¥2.34 Billion
≈ $342.87 Million
CN¥398.50 Million
≈ $58.31 Million
0.170x -0.47%
2014-12-31 CN¥2.32 Billion
≈ $339.57 Million
CN¥396.53 Million
≈ $58.02 Million
0.171x +19.83%
2013-12-31 CN¥2.20 Billion
≈ $322.38 Million
CN¥314.16 Million
≈ $45.97 Million
0.143x -2.08%
2012-12-31 CN¥2.08 Billion
≈ $304.06 Million
CN¥302.59 Million
≈ $44.28 Million
0.146x -15.34%
2011-12-31 CN¥1.98 Billion
≈ $290.15 Million
CN¥341.05 Million
≈ $49.91 Million
0.172x +8.44%
2010-12-31 CN¥1.80 Billion
≈ $263.37 Million
CN¥285.49 Million
≈ $41.78 Million
0.159x -22.16%
2009-12-31 CN¥1.78 Billion
≈ $260.89 Million
CN¥363.29 Million
≈ $53.16 Million
0.204x -16.01%
2008-12-31 CN¥787.10 Million
≈ $115.18 Million
CN¥190.97 Million
≈ $27.94 Million
0.243x +7.63%
2007-12-31 CN¥729.25 Million
≈ $106.71 Million
CN¥164.39 Million
≈ $24.06 Million
0.225x -35.03%
2006-12-31 CN¥627.33 Million
≈ $91.80 Million
CN¥217.67 Million
≈ $31.85 Million
0.347x --

About Guilin Sanjin Pharmaceutical Co Ltd

SHE:002275 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.15 Billion
CN¥7.89 Billion CNY
Market Cap Rank
#8518 Global
#2147 in China
Share Price
CN¥13.43
Change (1 day)
+0.07%
52-Week Range
CN¥13.35 - CN¥17.38
All Time High
CN¥19.61
About

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China and internationally. The company offers three gold particles, Guilin watermelon frost, watermelon frost lozenges, throat clearing spray, Naomaitai capsules, vertigo tablets, Xuanyunning granules, Gejie dingchuan capsule, compound panax notoginseng stomachache … Read more